pheochromocytoma
PHEOCHROMOCYTOMA
Pheochromocytoma is a rare adrenal gland tumor that may precipitate life-threatening hypertension.
It can occur at any age but usually occurs during young to mid-adult life.
Majority of patients presents with ≥1 of the following hypertension resistant to standard antihypertensive treatment, hypertensive crisis with malignant hypertension, hypertensive encephalopathy, aortic dissection, or myocardial infarction and paroxysmal symptoms which suggest seizure disorder, anxiety attacks or hyperventilation.

Surgical Intervention

  • Treatment of choice for most cases of pheochromocytoma
  • Should be performed in experienced centers
  • It is microscopically difficult to determine if pheochromocytoma is malignant
  • Each pheochromocytoma should be regarded as potentially malignant during surgery
    • The entire gland & the surrounding tissues must be removed to prevent recurrence of local disease
  • Preoperative pharmacologic management involves alpha & beta adrenergic blockade to control blood pressure & prevent hypertensive crisis during the surgical procedure
    • A high-sodium diet w/ increased fluid intake is recommended pre-op to prevent post-operative volume depletion
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Aug 2018
Men and women who regularly eat seafood appear to have higher sexual intercourse frequency (SIF) and fecundity in a large prospective cohort of couples attempting pregnancy, suggests a study.
29 Oct 2018
Whole-grain rice significantly reduces postprandial blood glucose response relative to white rice, results of a systematic review and meta-analysis have shown.
Tristan Manalac, 5 days ago
Poor aerobic fitness leads to high ectopic fat deposits which, in turn, lowers insulin sensitivity and increases insulin secretion in healthy, nonobese Asians, according to a Singapore study.
01 May 2016
Tadalafil on-demand and once-daily dosing regimens were effective in clinical subgroups of men with erectile dysfunction, according to pooled analyses of placebo-controlled studies.